Melanoma cells can tolerate high levels of transcriptionally active endogenous p53 but are sensitive to retrovirus-transduced p53

Oncogene

Volumn 22, Issue 31, 2003, Pages 4911-4917

  Kichina, Julia V ^a   Rauth, Sikha ^b   Das Gupta, Tapas K ^b   Gudkov, Andrei V ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Ing1; Melanoma; p53; Transactivation; Tumor suppressor

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; GAG PROTEIN; ISOPROTEIN; PROTEIN; PROTEIN P14; PROTEIN P16; PROTEIN P21; PROTEIN P33; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE LOCUS; GENETIC TRANSDUCTION; GENOTOXICITY; HUMAN; HUMAN CELL; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; RETROVIRUS; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; TRANSACTIVATION; WILD TYPE;

APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; CELL CYCLE PROTEINS; CHLORAMPHENICOL O-ACETYLTRANSFERASE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA-BINDING PROTEINS; GAMMA RAYS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GENES, REPORTER; GENES, TUMOR SUPPRESSOR; GENETIC VECTORS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MELANOMA; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEINS; RECOMBINANT FUSION PROTEINS; RETROVIRIDAE; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

UNIDENTIFIED RETROVIRUS;

EID: 0042066359     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206741     Document Type: Article

References (53)

1. Abarzua P, LoSardo JE, Gubler ML and Neri A. (1995). Cancer Res., 55, 3490-3494.
2. ACS (2002). Cancer Facts and Figures 2002. American Cancer Society: Atlanta.
3. Albino AP, Vidal MJ, McNutt NS, Shea CR, Prieto VG, Nanus DM, Palmer JM and Hayward NK. (1994). Melanoma Res., 4, 35-45.
4. Bae I, Smith ML, Sheikh MS, Zhan Q, Scudiero DA, Friend SH, O'Connor PM and Fornace Jr AJ. (1996). Cancer Res, 56, 840-847.
5. Bigner SH, Rasheed BK, Wiltshire R and McLendon RE. (1999). Neurooncol, 1, 52-60.
6. Birch JM, Blair V, Kelsey AM, Evans DG, Harris M, Tricker KJ and Varley JM. (1998). Oncogene, 17, 1061-1068.
7. Blagosklonny MV. (2000). FASEB J., 144, 1901-1907.
8. Campos Jr EI, Cheung KJ, Murray A, Li S and Li G. (2002). Br. J. Dermatol., 146, 574-580.
9. Cheung Jr KJ, Bush JA, Jia W and aand Li G. (2000). Br. J. Cancer, 83, 1468-1472.
10. Chin L, Merlino G and DePinho RA. (1998). Genes Dev., 12, 3467-3481.
11. Cirielli C, Riccioni T, Yang C, Pili R, Gloe T, Chang J, Inyaku K, Passaniti A and Capogrossi MC. (1995). Int. J. Cancer, 63, 673-679.
12. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS and Bradley A. (1992). Nature, 356, 215-221.
13. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. (1993). Cell, 75, 817-825.
14. Gallion HH, Pieretti M, DePriest PD and van Nagell Jr JR. (1995). Cancer, 76, 1992-1997.
15. Garkavtsev I, Boland D, Mai J, Wilson H, Veillette C and Riabowol K. (1997). Hybridoma, 16, 537-540.
16. Garkavtsev I, Grigorian IA, Ossovskaya VS, Chernov MV, Chumakov PM and aand Gudkov AV. (1998). Nature, 391, 295-298.
17. Harvey DM and Levine AJ. (1991). Genes Dev., 5, 2375-2385.
18. Haupt Y, Maya R, Kazaz A and Oren M. (1997). Nature, 387, 296-299.
19. Hollstein M, Sidransky D, Vogelstein B and Harris CC. (1991). Science, 253, 49-53.
20. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PA, Ally DS, Sheahan MD, Clark Jr WH, Tucker MA and Dracopoli NC. (1994). Nat Genet., 8, 15-21.
21. Kastan MB, Zhan Q, el-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B and Fornace Jr AJ. (1992). Cell, 71, 587-597.
22. Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Prives C and Vogelstein B. (1991). Science, 252, 1708-1711.
23. Kichina J, Green A and Rauth S. (1996). Pigment Cell Res., 9, 85-91.
24. Leung KM, Po LS, Tsang FC, Siu WY, Lau A, Ho HT and Poon RY. (2002). Cancer Res., 62, 4890-4893.
25. Loggini B, Rinaldi I, Pingitore R, Cristofani R, Castagna M and Barachini P. (2001). Tumori, 87, 179-186.
26. Matlashewski GJ, Tuck S, Pim D, Lamb P, Schneider J and Crawford LV. (1987). Mol. Cell Biol., 7, 961-963.
27. Mehta RR, Bratescu L, Graves JM, Shilkaitis A, Green A, Mehta RG and Das Gupta TK. (2002). Melanoma Res., 12, 27-33.
28. Mietz JA, Unger T, Huibregtse JM and aand Howley PM. (1992). EMBO J., 11, 5013-5020.
29. Moll UM, Ostermeyer AG, Haladay R, Winkfield B, Frazier M and Zambetti G. (1996). Mol. Cell Biol., 16, 1126-1137.
30. Montano X, Shamsher M, Whitehead P, Dawson K and Newton J. (1994). Oncogene, 9, 1455-1459.
31. Mora PT, Chandrasekaran K, Hoffman JC and McFarland VW. (1982). Mol. Cell Biol., 2, 763-771.
32. Nouman GS, Angus B, Lunec J, Crosier S, Lodge A and Anderson JJ. (2002). Hybrid Hybridomics, 21, 1-10.
33. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC and Hainaut P. (2002). Hum Mutat, 19, 607-614.
34. Pear WS, Nolan GP, Scott ML and Baltimore D. (1993). Proc. Natl. Acad. Sci. USA, 90, 8392-8396.
35. Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C and DePinho RA. (1998). Cell, 92, 713-723.
36. Ragnarsson-Olding BK, Karsberg S, Platz A and Ringborg UK. (2002). Melanoma Res., 12, 453-463.
37. Rass K, Gutwein P, Welter C, Meineke V, Tilgen W and Reichrath J. (2001). Histochem. J., 33, 459-467.
38. Rauth S and Davidson RL. (1993). Somat. Cell. Mol. Genet., 19, 285-293.
39. Rauth S, Green A, Bratescu L and Das Gupta TK. (1994a). In vitro Cell Dev. Biol. Anim., 30A, 79-84.
40. Rauth S, Kichina J, Green A, Bratescu L and Das Gupta TK. (1994b). Anticancer Res., 14, 2457-2463.
41. Renzing J and Lane DP. (1995). Oncogene, 10, 1865-1868.
42. Salti G, Kichina JV, Das Gupta TK, Uddin S, Bratescu L, Pezzuto JM, Mehta RG and Constantinou AI. (2001). Melanoma Res., 11, 99-104.
43. Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, McCombie R, Herman JG, Gerald WL, Lazebnik YA, Cordon-Cardo C and Lowe SW. (2001). Nature, 409, 207-211.
44. Soussi T and Beroud C. (2001). Nat. Rev. Cancer, 1, 233-240.
45. Sunamura M, Yatsuoka T, Motoi F, Duda DG, Kimura M, Abe T, Yokoyama T, Inoue H, Oonuma M, Takeda K and Matsuno S. (2002). J. Hepatobiliary Pancreat Surg., 9, 32-38.
46. Tannapfel A, Busse C, Weinans L, Benicke M, Katalinic A, Geissler F, Hauss J and Wittekind C. (2001). Oncogene, 20, 7104-7109.
47. Vogelstein B, Lane D and Levine AJ. (2000). Nature, 408, 307-310.
48. Wistuba II, Gazdar AF and Minna JD. (2001). Semin. Oncol., 3-13.
49. Yamamoto M and Takahashi H. (1993). Virchows Arch. A Pathol. Anat. Histopathol., 422, 127-132.
50. Yew PR and Berk AJ. (1992). Nature, 357, 82-85.
51. Yin Y, Tainsky MA, Bischoff FZ, Strong LC and Wahl GM. (1992). Cell, 70, 937-948.
52. Zeremski M, Hill JE, Kwek SS, Grigorian IA, Gurova KV, Garkavtsev IV, Diatchenko L, Koonin EV and Gudkov AV. (1999). J. Biol. Chem., 274, 32172-32181.
53. Zhang Y, Xiong Y and Yarbrough WG. (1998). Cell, 92, 725-734.